[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637137":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":72,"collaborators":25,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":25,"eligibilityCriteria":80,"healthyVolunteers":76,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":25,"studyType":87,"phases":88,"briefSummary":91,"conditions":92,"keywords":94,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"Aurinia Pharmaceuticals Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Aritinercept","EXPERIMENTAL","Double-Blind Treatment Period: Aritinercept by subcutaneous injection Open-Label Treatment Period: Aritinercept by subcutaneous injection",[13],"Drug: Aritinercept",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Double-Blind Treatment Period: Placebo by subcutaneous injection Open-Label Treatment Period: Aritinercept by subcutaneous injection",[13,19],"Other: Placebo",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","For subcutaneous injection",[9,15],null,{"type":27,"name":15,"description":23,"armGroupLabels":28,"otherNames":25},"OTHER",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Aurinia Clinical Trials Information","CONTACT","833-606-5975","clinicaltrials@auriniapharma.com",[36,52,62],{"facility":37,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Aurinia Investigational Site","RECRUITING","Altamonte Springs","Florida","32714","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-81.36562,28.66111,{"lat":48,"lon":47},[51],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},{"facility":37,"status":38,"city":53,"state":40,"zip":54,"country":42,"countryCode":43,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"Boca Raton","33487",{"type":45,"coordinates":56},[57,58],-80.0831,26.35869,{"lat":58,"lon":57},[61],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},{"facility":37,"status":38,"city":63,"state":40,"zip":64,"country":42,"countryCode":43,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Miami","33173",{"type":45,"coordinates":66},[67,68],-80.19366,25.77427,{"lat":68,"lon":67},[71],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},{"type":73,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100637137","phase-1-study-of-aritinercept-in-patients-with-generalized-myasthenia-gravis-100637137",false,"NCT07596901","Study of Aritinercept in Patients With Generalized Myasthenia Gravis","A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF\u002FAPRIL Inhibitor, in Patients With Generalized Myasthenia Gravis","Key Inclusion Criteria:\n\n* Adult patients (18-85 years old)\n* Myasthenia Gravis Foundation of America (MGFA) Class II-IV gMG\n* Additional inclusion criteria are defined in the protocol\n\nKey Exclusion Criteria:\n\n* Current or medical history of malignancy within the last 5 years\n* Pregnant, breastfeeding or intending to become pregnant during the Study\n* Additional exclusion criteria are defined in the protocol","ALL","18 Years","85 Years",{"count":85,"type":86},81,"ESTIMATED","INTERVENTIONAL",[89,90],"PHASE1","PHASE2","This clinical study will enroll patients with generalized myasthenia gravis (gMG). The goal of this clinical study is to assess the safety, tolerability, effectiveness, pharmacokinetics (how the body processes the drug) and pharmacodynamics (how the drug affects the body) of aritinercept.",[93],"Myasthenia Gravis, Generalized",[95],"aritinercept","2026-05-13",{"date":98,"type":99},"2026-05-19","ACTUAL",{"date":101,"type":99},"2026-04-22",{"date":103,"type":86},"2029-03-02",{"name":5,"class":6},3]